10
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10156 | CCR3 antagonist 1 | CCR | Immunology/Inflammation; Microbiology/Virology |
CCR3 antagonist 1是一种有效的 CCR3拮抗药,用于炎症和免疫疾病的研究。 | |||
T11699 |
J-113863
|
CCR | Immunology/Inflammation; Microbiology/Virology |
J-113863 是选择性的 CCR1 (CD18)拮抗剂,有抗炎作用,对人和小鼠 CCR1受体的 IC50值分别为 0.9 和 5.8 nM。它是人 CCR3的强效拮抗剂,还是小鼠 CCR3的弱效拮抗剂,IC50分别为 0.58 和 460 nM。 | |||
T23321 |
SB 328437
(S)-methyl 2-(1-naphthamido)-3-(4-nitrophenyl)propanoate,ZINC29222893 |
CCR | Immunology/Inflammation; Microbiology/Virology |
SB 328437 ((S)-methyl 2-(1-naphthamido)-3-(4-nitrophenyl)propanoate)是一种有效和选择性的CCR3拮抗剂(IC50 = 4.5 nM)。 | |||
T4674 |
SB297006
SB 297006 |
CCR | Immunology/Inflammation; Microbiology/Virology |
SB297006 是一种CCR3拮抗剂,IC50为39 nM。它能够显著抑制 CCL11 处理的神经祖细胞的增殖和神经球形成。 | |||
T11521 |
GW 766994
GW 994 |
CCR | Immunology/Inflammation; Microbiology/Virology |
GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist. It has the potential for asthma and eosinophilic bronchitis treatment. | |||
T30535 |
BMS-639623
UNII-PON9OFP69G,PON9OFP69G,BMS 639623,CHEMBL399495 |
||
BMS-639623 is a CCR3 antagonist with a picomolar inhibitory effect on eosinophilic chemotaxis and can be used in the treatment of asthma. | |||
T36620 |
ALK4290
ALK4290 |
||
ALK4290 (AKST4290) is a potent and orally actively CCR3 inhibitor, compound Example 2, with a Ki of 3.2 nM for hCCR3[1]. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism[2][3]. | |||
T23492 |
UCB 35625
|
Others | Others |
chemokine CCR1 and CCR3 receptor antagonist | |||
T30865 |
CH-0076989
UNII-9E629B19WL,CHEMBL485834,9E629B19WL,CH 0076989 |
||
CH-0076989 is a chemokine receptor CCR3 agonist. | |||
T76504 |
CKLF1-C19
|
||
CKLF1-C19 是人类趋化因子样因子 1 (CKLF1) 的 C 端肽。CKLF1-C19 与 CCR4相互作用,抑制 CKLF1 和 CCL17诱导的趋化性。CKLF1-C19 可以通过抑制 CCR3和 CCR4介导的趋化性来抑制过敏性肺部炎症。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T75499 | Maceneolignan H | ||
Maceneolignan H (Compound 8)是一种新的木脂素化合物,从肉豆蔻假种皮中分离而来。它表现为选择性CCR3拮抗剂(EC50=1.4 μM),具有研究过敏性疾病潜力。 |